Inhibition potentiates immunogenicity in Merkel cell carcinoma: a promising approach to overcome resistance to anti-PD-1 immunotherapy

被引：0

作者：

Chen, Wenwen ^{[1
]}

Bhatia, Shailender ^{[1
]}

Brohl, Andrew S. ^{[2
]}

Chandra, Sunandana ^{[3
]}

Dakhil, Sumia ^{[1
]}

Fecher, Leslie A. ^{[4
]}

Gao, Ling ^{[5
]}

Gooley, Ted A. ^{[6
]}

Hanna, Glenn J. ^{[7
]}

Hibbert, Reina

Kelly, Ciara M. ^{[8
]}

Kiriluk, Samantha M.

Lewis, Karl ^{[9
]}

Moschos, Stergios ^{[10
]}

Nghiem, Paul ^{[11
]}

Thompson, John A. ^{[1
]}

Tykodi, Scott S. ^{[1
]}

机构：

[1] Univ Washington, Seattle, WA USA

[2] Moffit Canc Ctr, Tampa, FL USA

[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[4] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA

[6] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA USA

[7] Dana Farber Canc Inst, Boston, MA USA

[8] Mem Sloan Kettering Canc Ctr, New York, NY USA

[9] Univ Colorado Canc Ctr, Anschutz Med Campus, Aurora, CO USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA

[11] Univ Washington, Div Dermatol, Seattle, WA USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2022年 / 142卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：2837 / 2837

页数：1

共 50 条

[21] HIGH DIMENSIONAL PROFILING OF MERKEL CELL POLYOMAVIRUS-SPECIFIC T CELLS IN RESPONSE TO ANTI-PD-1 IMMUNOTHERAPY
Ryu, Heeju
Bi, Timothy
Sarkar, Korok
Church, Candice
Ramchurren, Nirasha
Pulliam, Thomas
Fling, Steven
Nghiem, Paul
Newell, Evan
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1087 - A1087
[22] Anti-PD-L1-Immunotherapy: Effective Treatment for Patients with metastatic Merkel Cell Carcinoma
Schlinsog, Anne-Sophie
Sunderkoetter, C.
Moritz, Rose K. C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 24 - 24
[23] DDR2 inhibition enhances response to anti-PD-1 immunotherapy
Tu, Megan M.
Lee, Francis Y.
Jones, Robert T.
Kimball, Abigail K.
Saravia, Elizabeth
Graziano, Robert F.
Coleman, Brianne
Menard, Krista
Yan, Jun
Michaud, Erin
Chang, Han
Abdel-Hafiz, Hany A.
Rozhok, Andrii I.
Duex, Jason E.
Agarwal, Neeraj
Chauca-Diaz, Ana
Johnson, Linda K.
Ng, Terry L.
Cambier, John C.
Clambey, Eric T.
Costello, James C.
Korman, Alan J.
Theodorescu, Dan
CANCER RESEARCH, 2019, 79 (13)
[24] SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy
Wang, Peng
Qiu, Jiannan
Fang, Yuan
Li, Songmao
Liu, Kua
Cao, Yin
Zhang, Guang
Wang, Zhongxia
Gu, Xiaosong
Wu, Junhua
Jiang, Chunping
CELL DEATH AND DIFFERENTIATION, 2025,
[25] Mechanisms of resistance to anti-PD-1 immunotherapy through interferon pathway mutations
Zaretsky, Jesse
Garcia-Diaz, Angel
Shin, Daniel S.
Escuin-Ordinas, Helena
Hugo, Willy
Hu-Lieskovan, Siwen
Eroglu, Zeynep
Torrejon, Davis Y.
Tumeh, Paul C.
Lo, Roger S.
Ribas, Antoni
CANCER RESEARCH, 2017, 77
[26] Biomarkers of response to PD-1 inhibition in Merkel cell carcinoma
Spassova, I
Ugurel, S.
Kubat, L.
Terheyden, P.
Hassel, J.
Schadendorf, D.
Becker, J. C.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 5 - 5
[27] Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature
Tang, Zhengwu
Fang, Rui
Tong, Guihui
Liu, Peng
Ou, Zhu'an
Tang, Yong
LUNG CANCER, 2020, 146 : 335 - 340
[28] PD-1 inhibition in advanced Merkel-cell carcinoma
Baker, Holly
LANCET ONCOLOGY, 2016, 17 (06): : E225 - E225
[29] AST-008: A novel approach to TLR9 agonism with PD-1 blockade for anti-PD-1 refractory Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (CSCC).
Milhem, Mohammed M.
Perez, Cesar Augusto
Hanna, Glenn J.
Wise-Draper, Trisha Michel
Bhatia, Shailender
Bexon, Alice Susannah
Daniel, Weston L.
O'Day, Steven
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[30] A new enhancer for anti-PD-1/PD-L1 immunotherapy: PCSK9 inhibition
Sun, Shengbo
Yang, Zhengyang
Yao, Hongwei
Zhang, Zhongtao
TRENDS IN CANCER, 2025, 11 (02) : 84 - 87

← 1 2 3 4 5 →